PRIMARY BILIARY CHOLANGITIS (PBC)

Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.

Never miss a new study

Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear

Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 3 Completed 3

One pill may tame both itchy skin and stubborn liver disease

Disease control Not yet recruiting

This study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…

Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)

Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control

Last updated Jul 02, 2026 03:00 UTC

PRIMARY BILIARY CHOLANGITIS (PBC)

Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear

One pill may tame both itchy skin and stubborn liver disease